恩多勒吉克斯
ELGX

股本结构

单位：万股
公告日期 2020-08-10 2020-08-10 2020-05-27 2020-05-27 2020-03-11 2020-03-11
证券总股本 2065.72 1917.38 1917.17 1909.75 1909.23 1809.85
普通股本 2065.72 1917.38 1917.17 1909.75 1909.23 1809.85
优先股 未披露 1.46 未披露 1.46 未披露 未披露
其他 未披露 未披露 未披露 未披露 未披露 未披露
变动日期 2020-08-04 2020-06-30 2020-05-18 2020-03-31 2020-03-04 2019-12-31
注释：中概股证券总股本=普通股股本/ 存托凭证比例

历史变动

公告日期 变动后普通股本（万股） 变动后优先股（万股） 变动原因 变动日期
2020-08-10 2065.72 未披露 定期报告 2020-08-04
2020-08-10 1917.38 1.46
更多>>
From March 31, 2020 to June 30, 2020 Treasury shares purchased Issuance of restricted stock Issuance of common stock
2020-06-30
2020-05-27 1917.17 未披露 定期报告 2020-05-18
2020-05-27 1909.75 1.46
更多>>
From December 31, 2019 to March 31, 2020 Treasury shares purchased Issuance of restricted stock Issuance of common stock Issuance of Series DF-1 Preferred Stock
2020-03-31
2020-03-11 1909.23 未披露 定期报告 2020-03-04
2020-03-11 1809.85 未披露
更多>>
From December 31, 2018 to December 31, 2019 Employee stock purchase plan Issuance of common stock Treasury stock purchased Issuance of restricted stock Shares issued upon conversion of debt
2019-12-31
2019-11-07 1794.21 未披露 定期报告 2019-11-04
2019-11-07 1788.11 未披露
更多>>
from June 30, 2019 to September 30, 2019 Shares issued upon conversion of debt Issuance of restricted stock Treasury shares purchased
2019-09-30
2019-08-09 1761.27 未披露 定期报告 2019-08-06
2019-08-09 1735.27 未披露
更多>>
from March 31, 2019 to June 30, 2019 Employee stock purchase plan Treasury stock purchased Issuance of restricted stock Issuance of common stock Shares issued upon conversion of debt
2019-06-30
2019-07-08 1735.14 未披露 定期报告 2019-06-19
2019-05-08 1678.70 未披露 定期报告 2019-05-06
2019-04-30 1677.30 未披露 定期报告 2019-04-26
2019-04-30 1677.18 未披露 定期报告 2019-04-05
2019-05-08 1034.78 未披露
更多>>
from December 31, 2018 to March 31, 2019 Issuance of common stock Treasury stock purchased
2019-03-31
2019-04-01 1034.79 未披露 定期报告 2019-03-27
2019-04-01 1034.54 未披露
更多>>
from December 31, 2017 to March 6, 2019 Exercise of common stock options, net of shares withheld to cover exercise price Employee stock purchase plan Issuance of common stock Treasury stock purchased Issuance of restricted stock The Company’s Board of Directors had previously directed that the proposal be submitted to the stockholders for approval and has subsequently approved the reverse stock split at a ratio of 1-for-10. The reverse stock split will take effect at 4:00 p.m. ET on March 5, 2019. Beginning with the opening of trading on March 6, 2019, the Company's common stock will trade on the NASDAQ Global Select Market on a reverse stock split-adjusted basis.As a result of the reverse split, there will be approximately 10.3 million shares of common stock issued and outstanding.
2019-03-06
2018-11-08 10345.37 未披露 定期报告 2018-11-07
2018-11-08 8546.54 未披露 定期报告 2018-09-30
2018-08-09 8470.72 未披露 定期报告 2018-06-30
2018-05-09 8401.03 未披露 定期报告 2018-05-04
2018-04-17 8398.52 未披露 定期报告 2018-04-16
2018-05-09 8399.68 未披露 定期报告 2018-03-31
2018-03-13 8372.52 未披露 定期报告 2018-03-12
2018-03-13 8364.36 未披露
更多>>
from December 31, 2016 to December 31, 2017 Exercise of common stock options Employee stock purchase plan Issuance of restricted stock
2017-12-31
2017-11-07 8345.37 未披露 定期报告 2017-11-06
2017-11-07 8343.47 未披露 定期报告 2017-09-30
2017-08-04 8343.47 未披露 定期报告 2017-08-01
2017-08-02 8342.67 未披露 定期报告 2017-06-30
2017-05-05 8297.51 未披露 定期报告 2017-05-01
2017-05-01 8296.91 未披露 定期报告 2017-04-13
2017-05-05 8295.53 未披露 定期报告 2017-03-31
2017-03-01 8292.53 未披露 定期报告 2017-02-27
2017-03-01 8277.40 未披露
更多>>
From December 31, 2015 to December 31, 2016 Exercise of common stock options Employee stock purchase plan Issuance of common stock Treasury stock purchased Issuance of restricted stock
2016-12-31
2016-11-08 8269.11 未披露 定期报告 2016-11-03
2016-11-01 8244.41 未披露 定期报告 2016-09-30
2016-08-05 8237.29 未披露 定期报告 2016-08-01
2016-08-02 8231.23 未披露 定期报告 2016-06-30
2016-05-10 8181.93 未披露 定期报告 2016-05-05
2016-05-02 8177.09 未披露 定期报告 2016-04-13
2016-05-10 8175.90 未披露
更多>>
In connection with its merger with TriVascular Technologies, Inc. ("TriVascular") in February 2016, the Company issued 13.6 million shares of common stock as consideration to the former stockholders.
2016-03-31
2016-01-06 6803.04 未披露 定期报告 2016-01-04
2016-02-29 6803.44 未披露
更多>>
from December 31, 2014 to December 31, 2015 Exercise of common stock options Employee stock purchase plan Issuance of restricted stock Treasury stock purchased
2015-12-31
2015-12-18 6803.28 未披露 定期报告 2015-12-17
2015-10-30 6778.95 未披露 定期报告 2015-10-26
2015-10-26 6778.93 未披露 定期报告 2015-10-23
2015-10-30 6778.89 未披露 定期报告 2015-09-30
2015-08-05 6778.11 未披露 定期报告 2015-07-31
2015-08-03 6776.77 未披露 定期报告 2015-06-30
2015-04-17 6741.84 未披露 定期报告 2015-04-13
2015-04-29 6741.52 未披露 定期报告 2015-03-31
2015-03-02 6719.41 未披露 定期报告 2015-02-20
2015-03-02 6715.95 未披露
更多>>
From December 31,2013 to December 31,2014 Exercise of common stock options Employee stock purchase plan Issuance of common stock Treasury stock purchased Issuance of restricted stock
2014-12-31
2014-10-30 6698.84 未披露 定期报告 2014-09-30
2014-07-31 6695.35 未披露 定期报告 2014-07-28
2014-07-30 6690.94 未披露 定期报告 2014-06-30
2014-04-18 6401.38 未披露 定期报告 2014-04-14
2014-05-02 6400.50 未披露 定期报告 2014-03-31
2014-03-03 6386.92 未披露 定期报告 2014-02-24
2014-03-03 6386.64 未披露
更多>>
From December 31,2012 to December 31,2013 Exercise of common stock options Employee stock purchase plan Issuance of common stock Treasury stock retired Issuance of restricted stock
2013-12-31
2013-11-01 6353.66 未披露 定期报告 2013-10-25
2013-10-30 6342.07 未披露 定期报告 2013-09-30
2013-08-05 6313.23 未披露 定期报告 2013-07-26
2013-07-30 6303.93 未披露 定期报告 2013-06-30
2013-05-07 6279.90 未披露 定期报告 2013-03-31
2013-03-14 6265.41 未披露 定期报告 2013-02-28
2013-03-14 6257.38 未披露
更多>>
from December 31, 2011 to December 31, 2012 Exercise of common stock options Employee stock purchase plan Sale of common stock Issuance of restricted stock Cancellation of restricted stock
2012-12-31
2012-11-01 6195.65 未披露 定期报告 2012-10-25
2012-11-01 6187.10 未披露 定期报告 2012-09-30
2012-08-03 6135.56 未披露 定期报告 2012-08-01
2012-08-03 6133.20 未披露 定期报告 2012-06-30
2012-05-10 5823.95 未披露 定期报告 2012-05-01
2012-04-26 5822.78 未披露 定期报告 2012-03-31
2012-03-06 5818.06 未披露 定期报告 2012-02-24
2012-03-06 5808.28 未披露
更多>>
from December 31, 2010 to December 31, 2011 Exercise of common stock options Employee stock purchase plan
2011-12-31
2011-10-31 5764.16 未披露 定期报告 2011-10-26
2011-10-27 5762.50 未披露 定期报告 2011-09-30
2011-08-03 5751.80 未披露 定期报告 2011-07-28
2011-08-03 5723.10 未披露 定期报告 2011-06-30
2011-05-10 5675.65 未披露 定期报告 2011-05-02
2011-05-10 5658.90 未披露 定期报告 2011-03-31
2011-03-16 5604.88 未披露 定期报告 2011-02-25
2011-03-16 5640.10 未披露
更多>>
Exercise of common stock options Employee stock purchase plan Sale of Common Stock Issuance of Common Stock for acquisition Grant of restricted stock
2010-12-31
2010-11-08 4900.90 未披露 定期报告 2010-11-05
2010-11-08 4899.70 未披露 定期报告 2010-09-30
2010-07-30 4896.00 未披露 定期报告 2010-07-13
2010-07-30 4895.80 未披露 定期报告 2010-06-30
2010-05-10 4866.43 未披露 定期报告 2010-04-13
2010-05-10 4868.60 未披露 定期报告 2010-03-31
2010-03-05 4868.05 未披露 定期报告 2010-02-10
2010-03-05 4865.70 未披露
更多>>
from December 31, 2008 to December 31, 2009 Exercise of common stock options Employee stock purchase plan Sale of Common Stock Grant of restricted stock
2009-12-31
2009-03-10 4387.04 未披露 定期报告 2009-02-10
2009-03-10 4387.00 未披露
更多>>
from December 31, 2007 to December 31, 2008 Exercise of common stock options Employee stock purchase plan Grant of restricted stock
2008-12-31
2008-02-29 4295.79 未披露 定期报告 2008-02-13
2008-02-29 4295.80 未披露
更多>>
from December 31, 2006 to December 31, 2007 Exercise of common stock options Employee stock purchase plan Grant of stock awards
2007-12-31
2007-03-12 4320.74 未披露 定期报告 2007-02-16
2007-03-12 4264.90 未披露
更多>>
from December 31, 2005 to December 31, 2006 Exercise of common stock options Employee stock purchase plan Sale of common stock Amortization of stock compensation expense
2006-12-31
2006-03-16 3703.27 未披露 定期报告 2006-03-01
2006-03-16 3618.40 未披露
更多>>
from December 31, 2004 to December 31, 2005 Exercise of common stock options Employee stock purchase plan Sale of Common stock
2005-12-31
2005-03-31 3190.47 未披露 定期报告 2005-03-07
2005-03-31 3186.70 未披露
更多>>
from December 31, 2003 to December 31, 2004 Exercise of common stock options Employee stock purchase plan Sale of Common stock
2004-12-31
2004-03-26 3167.69 未披露 定期报告 2004-03-11
2004-03-26 2808.10 未披露
更多>>
from December 31, 2002 to December 31, 2003 Exercise of common stock options Employee stock purchase plan Sale of Common stock Common stock repurchased
2003-12-31
2003-03-27 2437.00 未披露 定期报告 2003-03-14
2003-03-27 2408.70 未披露
更多>>
from December 31, 2001 to December 31, 2002 Exercise of common stock options Employee stock purchase plan Common stock issued in conjunction with a business combination Common stock repurchased
2002-12-31
2002-03-27 1316.80 未披露 定期报告 2002-03-14
2002-03-27 1312.20 未披露
更多>>
from December 31, 2000 to December 31, 2001 Exercise of common stock options Employee stock purchase plan
2001-12-31
2001-03-29 1306.70 未披露 定期报告 2001-03-13
2001-03-29 1304.90 未披露
更多>>
from DECEMBER 31,1999 to DECEMBER 31,2000 Exercise of common stock options Employee stock purchase plan Sale of common stock (net of costs of $1,217) Convertible debenture exercise
2000-12-31
2000-04-14 1202.10 未披露 定期报告 2000-03-15
2000-04-14 1121.00 未披露
更多>>
from December 31, 1998 to December 31, 1999 Acquisition of RMS Exercise of common stock options Employee stock purchase plan
1999-12-31
1999-03-31 1059.70 未披露 定期报告 1999-03-15
1999-03-31 889.20 未披露
更多>>
from December 31, 1997 to December 31, 1998 Exercise of common stock options Employee stock purchase plan Treasury shares purchased
1998-12-31
1998-03-01 941.30 未披露 定期报告 1998-03-01
1998-03-31 904.40 未披露
更多>>
from December 31, 1996 to December 31, 1997 Exercise of common stock options Employee stock purchase plan SCIMED warrant exercise Sale of common stock to Cathex Expense repayment by Intraluminal Devices, Inc. by transfer and cancellation of common stock Treasury Common Stock
1997-12-31
1997-03-26 908.09 未披露 定期报告 1997-03-07
1997-03-26 900.40 未披露
更多>>
from December 31, 1995 to December 31, 1996 Sale of Preferred Stock to EndoSonics Conversion of Preferred Stock Exercise of Common Stock Options Initial Public Offering of Common Stock Acquisition of Intraluminal Devices, Inc Conversion of $750,000 debt by Fukuda Denshi
1996-12-31
From March 31, 2020 to June 30, 2020 Treasury shares purchased Issuance of restricted stock Issuance of common stock
From December 31, 2019 to March 31, 2020 Treasury shares purchased Issuance of restricted stock Issuance of common stock Issuance of Series DF-1 Preferred Stock
From December 31, 2018 to December 31, 2019 Employee stock purchase plan Issuance of common stock Treasury stock purchased Issuance of restricted stock Shares issued upon conversion of debt
from June 30, 2019 to September 30, 2019 Shares issued upon conversion of debt Issuance of restricted stock Treasury shares purchased
from March 31, 2019 to June 30, 2019 Employee stock purchase plan Treasury stock purchased Issuance of restricted stock Issuance of common stock Shares issued upon conversion of debt
from December 31, 2018 to March 31, 2019 Issuance of common stock Treasury stock purchased
from December 31, 2017 to March 6, 2019 Exercise of common stock options, net of shares withheld to cover exercise price Employee stock purchase plan Issuance of common stock Treasury stock purchased Issuance of restricted stock The Company’s Board of Directors had previously directed that the proposal be submitted to the stockholders for approval and has subsequently approved the reverse stock split at a ratio of 1-for-10. The reverse stock split will take effect at 4:00 p.m. ET on March 5, 2019. Beginning with the opening of trading on March 6, 2019, the Company's common stock will trade on the NASDAQ Global Select Market on a reverse stock split-adjusted basis.As a result of the reverse split, there will be approximately 10.3 million shares of common stock issued and outstanding.
from December 31, 2016 to December 31, 2017 Exercise of common stock options Employee stock purchase plan Issuance of restricted stock
From December 31, 2015 to December 31, 2016 Exercise of common stock options Employee stock purchase plan Issuance of common stock Treasury stock purchased Issuance of restricted stock
In connection with its merger with TriVascular Technologies, Inc. ("TriVascular") in February 2016, the Company issued 13.6 million shares of common stock as consideration to the former stockholders.
from December 31, 2014 to December 31, 2015 Exercise of common stock options Employee stock purchase plan Issuance of restricted stock Treasury stock purchased
From December 31,2013 to December 31,2014 Exercise of common stock options Employee stock purchase plan Issuance of common stock Treasury stock purchased Issuance of restricted stock
From December 31,2012 to December 31,2013 Exercise of common stock options Employee stock purchase plan Issuance of common stock Treasury stock retired Issuance of restricted stock
from December 31, 2011 to December 31, 2012 Exercise of common stock options Employee stock purchase plan Sale of common stock Issuance of restricted stock Cancellation of restricted stock
from December 31, 2010 to December 31, 2011 Exercise of common stock options Employee stock purchase plan
Exercise of common stock options Employee stock purchase plan Sale of Common Stock Issuance of Common Stock for acquisition Grant of restricted stock
from December 31, 2008 to December 31, 2009 Exercise of common stock options Employee stock purchase plan Sale of Common Stock Grant of restricted stock
from December 31, 2007 to December 31, 2008 Exercise of common stock options Employee stock purchase plan Grant of restricted stock
from December 31, 2006 to December 31, 2007 Exercise of common stock options Employee stock purchase plan Grant of stock awards
from December 31, 2005 to December 31, 2006 Exercise of common stock options Employee stock purchase plan Sale of common stock Amortization of stock compensation expense
from December 31, 2004 to December 31, 2005 Exercise of common stock options Employee stock purchase plan Sale of Common stock
from December 31, 2003 to December 31, 2004 Exercise of common stock options Employee stock purchase plan Sale of Common stock
from December 31, 2002 to December 31, 2003 Exercise of common stock options Employee stock purchase plan Sale of Common stock Common stock repurchased
from December 31, 2001 to December 31, 2002 Exercise of common stock options Employee stock purchase plan Common stock issued in conjunction with a business combination Common stock repurchased
from December 31, 2000 to December 31, 2001 Exercise of common stock options Employee stock purchase plan
from DECEMBER 31,1999 to DECEMBER 31,2000 Exercise of common stock options Employee stock purchase plan Sale of common stock (net of costs of $1,217) Convertible debenture exercise
from December 31, 1998 to December 31, 1999 Acquisition of RMS Exercise of common stock options Employee stock purchase plan
from December 31, 1997 to December 31, 1998 Exercise of common stock options Employee stock purchase plan Treasury shares purchased
from December 31, 1996 to December 31, 1997 Exercise of common stock options Employee stock purchase plan SCIMED warrant exercise Sale of common stock to Cathex Expense repayment by Intraluminal Devices, Inc. by transfer and cancellation of common stock Treasury Common Stock
from December 31, 1995 to December 31, 1996 Sale of Preferred Stock to EndoSonics Conversion of Preferred Stock Exercise of Common Stock Options Initial Public Offering of Common Stock Acquisition of Intraluminal Devices, Inc Conversion of $750,000 debt by Fukuda Denshi
同花顺个股页面 | 模拟炒股 | 股民学校 | 手机炒股| 联系我们

免责声明:本信息由同花顺金融研究中心提供，仅供参考，同花顺金融研究中心力求但不保证数据的完全准确，如有错漏请以中国证监会指定上市公司信息披露媒体为准，同花顺金融研究中心不对因该资料全部或部分内容而引致的盈亏承担任何责任。用户个人对服务的使用承担风险。同花顺对此不作任何类型的担保。同花顺不担保服务一定能满足用户的要求，也不担保服务不会受中断，对服务的及时性，安全性，出错发生都不作担保。同花顺对在同花顺上得到的任何信息服务或交易进程不作担保。同花顺提供的包括同花顺理财的所有文章，数据，不构成任何的投资建议，用户查看或依据这些内容所进行的任何行为造成的风险和结果都自行负责，与同花顺无关。

【免责声明】本产品中的行情数据及资讯信息来源于第三方，长江证券不对收集数据的版权、真实性、准确性及传输过程中发生的传送错误承担法律责任。本内容仅供参考，不作为投资决策依据，长江证券不对因据此操作产生的盈亏承担任何责任。投资有风险，入市需谨慎。